Goldman Sachs
OCGN icon

Goldman Sachs’s Ocugen OCGN Stock Holding History

Goldman Sachs’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.04M Sell
1,127,406
-1,175,069
-51% -$2.03M ﹤0.01% 4535
2025
Q4 		$3.11M Buy
2,302,475
+2,204,765
+2,256% +$3.14M ﹤0.01% 4199
2025
Q3 		$159K Sell
97,710
-789,342
-89% -$875K ﹤0.01% 5996
2025
Q2 		$861K Buy
887,052
+286,373
+48% +$238K ﹤0.01% 4808
2025
Q1 		$424K Sell
600,679
-225,168
-27% -$156K ﹤0.01% 5281
2024
Q4 		$665K Sell
825,847
-106,890
-11% -$97.9K ﹤0.01% 5075
2024
Q3 		$925K Buy
932,737
+173,297
+23% +$238K ﹤0.01% 4686
2024
Q2 		$1.18M Sell
759,440
-1,848,185
-71% -$2.88M ﹤0.01% 4331
2024
Q1 		$4.28M Buy
+2,607,625
New +$2.19M ﹤0.01% 3239
2023
Q3 		– Sell
-70,669
Closed -$38.4K – 5763
2023
Q2 		$38.4K Sell
70,669
-634,231
-90% -$407K ﹤0.01% 5489
2023
Q1 		$601K Sell
704,900
-840,315
-54% -$916K ﹤0.01% 4728
2022
Q4 		$2.01M Sell
1,545,215
-448,705
-23% -$699K ﹤0.01% 3944
2022
Q3 		$3.55M Buy
1,993,920
+416,256
+26% +$1.04M ﹤0.01% 3454
2022
Q2 		$3.58M Buy
1,577,664
+596,736
+61% +$1.43M ﹤0.01% 3504
2022
Q1 		$3.24M Buy
980,928
+760,306
+345% +$2.67M ﹤0.01% 3775
2021
Q4 		$1M Sell
220,622
-4,777
-2% -$36.1K ﹤0.01% 4834
2021
Q3 		$1.62M Sell
225,399
-7,151
-3% -$52.5K ﹤0.01% 4373
2021
Q2 		$1.87M Sell
232,550
-94,018
-29% -$793K ﹤0.01% 4268
2021
Q1 		$2.22M Buy
326,568
+315,310
+2,801% +$2.1M ﹤0.01% 3887
2020
Q4 		$21K Buy
+11,258
New +$5.42K ﹤0.01% 5435
2017
Q3 		– Sell
-196
Closed -$21K – 6789
2017
Q2 		$21K Buy
+196
New +$20.1K ﹤0.01% 6547
2015
Q4 		– Sell
-193
Closed -$46K – 7283
2015
Q3 		$46K Sell
193
-153
-44% -$55.3K ﹤0.01% 6821
2015
Q2 		$134K Sell
346
-357
-51% -$172K ﹤0.01% 6443
2015
Q1 		$422K Buy
703
+211
+43% +$122K ﹤0.01% 5310
2014
Q4 		$325K Buy
+492
New +$325K ﹤0.01% 5705

Other funds holding OCGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Goldman Sachs's OCGN Position: Q1 2026 in Review

Goldman Sachs reduced its Ocugen (OCGN) stake by 51% in Q1 2026, selling an estimated $2.03M and leaving 1,127,406 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #4535.

Goldman Sachs first reported a position in OCGN in Q4 2014 and has held it in 25 quarters since. The position peaked at $4.28M in Q1 2024. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Goldman Sachs held 1,127,406 shares of Ocugen worth $2.04M as of Q1 2026.
  • Goldman Sachs sold 1,175,069 Ocugen shares in Q1 2026, an estimated $2.03M.
  • Ocugen made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4535 holding.
  • Goldman Sachs first reported a position in Ocugen in Q4 2014 and has held it in 25 quarters since.
  • Goldman Sachs's Ocugen position peaked at $4.28M in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.